Inside Penn

In brief, what’s happening at Penn—whether it’s across campus or around the world.

Filter Stories

Displaying 691 - 700 of 2520
  • ‘Organ-on-a-chip’ device provides new insights into early-stage pregnancy

    Researchers at the Biologically Inspired Engineering Systems (BIOLines) Laboratory in the Department of Engineering in the School of Engineering and Applied Sciences have recently developed a new variation of the organ-on-a-chip: one that replicates the interface between maternal tissue and the cells of the placenta at the critical moments in early pregnancy when the embryo is implanting in the uterus.

    FULL STORY AT Penn Medicine News

  • Weitzman to honor Diller Scofidio + Renfro and Hartford400

    The 2022 Kanter Tritsch Medal in Architecture and the 2022 Witte-Sakamoto Family Medal in City and Regional Planning are two of three professional honors bestowed annually by the Weitzman School of Design. They will be presented at a ceremony which raises funds for student scholarships on Feb. 23, 2023.

    FULL STORY AT Weitzman School of Design

  • Penn Medicine receives $3.5 million NCI grant to improve cervical cancer care in Botswana

    Penn Radiation Oncology has been working with colleagues in Botswana since 2011, where the cervical cancer mortality rate is 10 times higher than the U.S.

    FULL STORY AT Penn Medicine News

  • Is there a better way to staff temporary teams?

    Research from Wharton’s Hummy Song suggests a new strategy for staffing high-performing work teams by focusing on the relationships among members and not just their skills.

    FULL STORY AT Knowledge at Wharton

  • After early potential, cholesterol medication fenofibrate fails to cut severe symptoms or death in COVID-19 patients

    The drug was initially targeted for COVID-19 research as part of an effort to test older, previously approved drugs for potential benefit against the virus. Compared with a placebo, fenofibrate had no significant effect either on severity scores or death from any cause, among other metrics. Researchers say there could be a number of potential explanations for the drug’s failure to achieve the same results in humans that it did in laboratory cells.

    FULL STORY AT Penn Medicine News

  • Penn Dental Medicine ‘Making the Case for Health Justice for People with Disabilities’

    A 26-member delegation from Penn Dental Medicine including the dean, faculty, administrators, and alumni participated in a two-day conference on the topic of improving oral health care for persons with disabilities at the Hebrew University-Hadassah School of Dental Medicine in Jerusalem last month.

    FULL STORY AT Penn Dental Medicine

  • Michael E. Mann honored With Stroud Award for Freshwater Excellence

    The Stroud Water Research Center has awarded the 2022 Stroud Award for Freshwater Excellence to the Presidential Distinguished Professor of Earth and Environmental Science and director of the Penn Center for Science, Sustainability, and the Media for being a leading voice for climate change.

    FULL STORY AT Penn Arts & Sciences

  • Dennis Sourvanos awarded the 2022 American Society for Photobiology Frederick Urbach Student Travel Award

    The Penn Dental Medicine postdoctoral student was awarded the award, enabling him to present at the ASP Biennial Meeting. His research explores photobiomodulation treatment after dental surgery, with an emphasis on calculating dose and related mechanisms to induce tissue regeneration.

    FULL STORY AT Penn Dental Medicine

  • The new Chester County Hospital Behavioral Health team

    The CCH Behavioral Health team comprises twelve full-time and four part-time staff members, including eleven social workers and four treating behavioral health clinicians.

    FULL STORY AT Penn Medicine News

  • Peter Reese wins Distinguished Researcher Award from the American Society of Nephrology

    Reese is an NIH-funded transplant nephrologist and epidemiologist and a professor of medicine at the Perelman School of Medicine, whose accomplishments include co-leading the first kidney and heart trials of transplanting organs from donors with hepatitis C virus infection into uninfected recipients, followed by treatment with antiviral agents.

    FULL STORY AT Center for Health Incentives and Behavioral Economics